Acute non-ST-elevation acute coronary syndromes: Early antiplatelet therapy - UpToDate
uptodate.com · 295 words · saved by 1 readers
{{configCtrl2.info.metaDescription}}
Acute non-ST-elevation acute coronary syndromes: Initial antiplatelet therapy INTRODUCTION In patients with acute coronary syndromes (ACS), antiplatelet therapy inhibits platelet-mediated thrombosis and reduces the clinical risk of death and recurrent myocardial infarction (MI). This topic addresses the use of antiplatelet therapy in patients with acute non-ST-elevation acute coronary syndromes (NSTEACS) based on the strategy chosen for management (ie, invasive strategy, noninvasive strategy) (algorithm 1) and covers the initial approach (algorithm 2) to the type and timing of…
related reading
- Overview of the acute management of non-ST-elevation acute coronary syndromesuptodate.com
- Notionnotion.so
- Therapy for acute basilar artery occlusion: a systematic review and meta-analysisncbi.nlm.nih.gov
- Some Perspectives on Hypersensitivity to Coronary Stentsncbi.nlm.nih.gov
- 林世崇醫師 Alex Lin, MD, FACCmedclinical.wordpress.com
- Peripheral Arterial Disease - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Đánh giá chu phẫu tim mạch và xử trí | Vinmecvinmec.com
- Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka | BMC Cardiovascular Disorders | Springer Nature Linkbmccardiovascdisord.biomedcentral.com
- Sacubitril-Valsartan - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Antimicrobial therapy of left-sided native valve endocarditisuptodate.com
- Error - Cookies Turned Offonlinelibrary.wiley.com
- Guidance for Industryfda.gov